News

Filter

Current filters:

Albemarle

Impax confirms patent challenge to GlaxoSmithKline’s Jalyn; Albemarle hikes API prices

14-09-2011

US generic drugmaker Impax Laboratories (Nasdaq: IPXL) confirms that it has initiated a challenge of…

AlbemarleAvodartGenericsGlaxoSmithKlineImpax LaboratoriesJalynLegalNorth AmericaPatentsPricing

COMPANY SPOTLIGHT

Menarini

Back to top